A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

NCT05991388 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

210

Enrollment

OTHER

Sponsor class

Conditions

B-cell Non Hodgkin Lymphoma

Interventions

DRUG: Odronextamab
DRUG: Loncastuximab tesirine
DRUG: Rituximab
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Etoposide Phosphate
DRUG: Dexamethasone
BIOLOGICAL: CAR T-cells (TBC)

Sponsor

University of Birmingham

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]